TY  - RPRT
TI  - Drug resistance mechanisms create targetable proteostatic vulnerabilities in Her2+ breast cancers
AU  - Komurov, K.
AU  - Singh, N.
AU  - Privette-Vinnedge, L.
PY  - 2021
DO  - 10.1101/2021.08.18.456887
UR  - https://www.biorxiv.org/content/10.1101/2021.08.18.456887v1
ID  - 10.1101/2021.08.18.456887
ER  -